We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.2M
AUM Growth
+$10.1M
(+13%)
Cap. Flow
+$4.72M
Cap. Flow
% of AUM
5.35%
Top 10 Holdings %
Top 10 Hldgs %
27.76%
Holding
114
New
6
Increased
84
Reduced
17
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$801K |
| 2 |
InMode
INMD
|
+$412K |
| 3 |
Abbott
ABT
|
+$402K |
| 4 |
Robert Half
RHI
|
+$266K |
| 5 |
Comcast
CMCSA
|
+$266K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$749K |
| 2 |
Corpay
CPAY
|
+$635K |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$622K |
| 4 |
AMN Healthcare
AMN
|
+$407K |
| 5 |
KeyCorp
KEY
|
+$212K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.82% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 12.71% |
| 4 | Industrials | 10.23% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
TJX Companies
TJX
$174B
| $652K | 0.74% |
8,324
+416
| +5% | +$32.7K |
|
|
PRFT
52
DELISTED
Perficient Inc
PRFT
| $641K | 0.73% |
8,873
+2,695
| +44% | +$197K |
|
53
Blackrock
BLK
$169B
| $629K | 0.71% |
940
+53
| +6% | +$37.3K |
|
54
Edwards Lifesciences
EW
$49.6B
| $626K | 0.71% |
7,563
+211
| +3% | +$16.6K |
|
55
CDW
CDW
$18.9B
| $623K | 0.71% |
3,199
+99
| +3% | +$19.4K |
|
56
Chevron
CVX
$392B
| $602K | 0.68% |
3,692
+333
| +10% | +$55.8K |
|
57
American Water Works
AWK
$26.7B
| $598K | 0.68% |
4,083
+166
| +4% | +$24.6K |
|
58
Coca-Cola
KO
$377B
| $588K | 0.67% |
9,477
+444
| +5% | +$26.9K |
|
59
Timken Company
TKR
$9.56B
| $583K | 0.66% |
7,140
-27
| -0.4% | -$2.18K |
|
60
Moody's
MCO
$82.8B
| $579K | 0.66% |
1,893
+73
| +4% | +$22.1K |
|
61
Morgan Stanley
MS
$331B
| $567K | 0.64% |
6,462
+27
| +0.4% | +$2.52K |
|
62
Wells Fargo
WFC
$261B
| $532K | 0.6% |
14,244
+521
| +4% | +$22.7K |
|
63
Johnson & Johnson
JNJ
$618B
| $517K | 0.59% |
3,336
-223
| -6% | -$36K |
|
64
FMC
FMC
$1.34B
| $516K | 0.59% |
4,225
+143
| +4% | +$18K |
|
65
Gentex
GNTX
$4.97B
| $514K | 0.58% |
18,344
+334
| +2% | +$9.41K |
|
66
First American
FAF
$7.66B
| $513K | 0.58% |
9,209
+158
| +2% | +$9.07K |
|
67
Royal Caribbean
RCL
$85.1B
| $512K | 0.58% |
7,837
+1,405
| +22% | +$92.7K |
|
68
Bristol-Myers Squibb
BMY
$133B
| $491K | 0.56% |
7,083
+1,332
| +23% | +$93.9K |
|
69
Texas Instruments
TXN
$252B
| $478K | 0.54% |
2,569
+159
| +7% | +$28K |
|
70
Medtronic
MDT
$109B
| $474K | 0.54% |
5,879
+1,046
| +22% | +$85.3K |
|
71
Pool Corp
POOL
$6.75B
| $472K | 0.54% |
1,377
+4
| +0.3% | +$1.42K |
|
72
Accenture
ACN
$102B
| $466K | 0.53% |
1,632
+105
| +7% | +$28.6K |
|
|
BERY
73
DELISTED
Berry Global Group, Inc.
BERY
| $459K | 0.52% |
8,490
+196
| +2% | +$10.9K |
|
74
United Parcel Service
UPS
$88.6B
| $450K | 0.51% |
2,318
-70
| -3% | -$12.8K |
|
75
Xcel Energy
XEL
$48.8B
| $425K | 0.48% |
6,303
+469
| +8% | +$31.6K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, First National Advisers held 114 positions worth $88.2M, up 13% from $78.1M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
First National Advisers deployed $4.72M of net new capital in Q1 2023, opening 6 new positions and adding to 84 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 5,416 shares worth $793K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $749K trimmed.
- First National Advisers's largest Q1 2023 buy was Jazz Pharmaceuticals: 5,416 shares worth $793K.
- First National Advisers added most to Abbott in Q1 2023, an estimated $402K increase.
- First National Advisers's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $749K.
- First National Advisers fully exited Corpay in Q1 2023, selling an estimated $635K.
- First National Advisers's ten largest holdings make up 28% of its $88.2M portfolio in Q1 2023.
- First National Advisers opened 6 new positions and closed 4 in Q1 2023.
- First National Advisers's portfolio value rose 13% quarter-over-quarter to $88.2M.
Based on First National Advisers's 13F filing for Q1 2023, filed 10 May 2023.